Logo

Ono Entered into a Multi Target R&D Collaboration Agreement with PrecisionLife to Identify Novel Therapeutic Targets

Share this

Ono Entered into a Multi Target R&D Collaboration Agreement with PrecisionLife to Identify Novel Therapeutic Targets

Shots:

  • The collaboration utilizes PrecisionLife’s combinatorial analytics-generated insights to identify novel therapeutic targets & patient stratification biomarkers for CNS disorders to be developed by Ono
  • The collaboration strengthens PrecisionLife’s precision medicine & drug discovery capabilities & provides rights to Ono to select targets with genetic validation, mechanistic hypotheses, preclinical validation, and patient stratification biomarkers to optimize the clinical development of the assets
  • Ono also obtains the global rights to develop & commercialize a pharmaceutical product acting on the target. PrecisionLife has analyzed ~40 high-value disease indications & maintains a deep portfolio of insights and patented discoveries in its DiseaseBank repository

Ref: Ono Image: Ono

Click here to­ read the full press release 

Join the PharmaShots family of 12000+ subscribers

I accept the Terms and Conditions